Lincoln National Corp Gilead Sciences, Inc. Transaction History

Lincoln National Corp

  • $3.11 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024
BUY
$71.58 - $87.29 $100,355 - $122,380
1,402 Added 10.97%
14,180 $1.04 Million
Q4 2023

Feb 06, 2024
BUY
$73.27 - $83.09 $277,326 - $314,495
3,785 Added 42.09%
12,778 $1.04 Million
Q3 2023

Nov 03, 2023
BUY
$73.94 - $80.67 $103,294 - $112,695
1,397 Added 18.39%
8,993 $673,000
Q2 2023

Aug 04, 2023
SELL
$76.01 - $86.7 $9,957 - $11,357
-131 Reduced 1.7%
7,596 $585,000
Q1 2023

May 01, 2023
SELL
$77.31 - $88.08 $30,305 - $34,527
-392 Reduced 4.83%
7,727 $641,000
Q4 2022

Feb 07, 2023
SELL
$62.32 - $89.47 $234,073 - $336,049
-3,756 Reduced 31.63%
8,119 $697,000
Q3 2022

Nov 03, 2022
BUY
$59.54 - $68.01 $116,757 - $133,367
1,961 Added 19.78%
11,875 $733,000
Q2 2022

Aug 02, 2022
BUY
$57.72 - $65.01 $119,595 - $134,700
2,072 Added 26.42%
9,914 $613,000
Q1 2022

May 09, 2022
BUY
$57.92 - $72.58 $51,259 - $64,233
885 Added 12.72%
7,842 $466,000
Q4 2021

Jan 26, 2022
SELL
$64.88 - $73.64 $49,308 - $55,966
-760 Reduced 9.85%
6,957 $505,000
Q3 2021

Nov 05, 2021
BUY
$67.69 - $73.03 $24,977 - $26,948
369 Added 5.02%
7,717 $539,000
Q2 2021

Aug 13, 2021
BUY
$63.47 - $69.35 $99,901 - $109,156
1,574 Added 27.26%
7,348 $506,000
Q1 2021

May 10, 2021
BUY
$60.0 - $68.46 $1,260 - $1,437
21 Added 0.37%
5,774 $374,000
Q4 2020

Feb 05, 2021
SELL
$56.65 - $64.55 $56,650 - $64,550
-1,000 Reduced 14.81%
5,753 $335,000
Q3 2020

Nov 09, 2020
BUY
$62.1 - $78.08 $21,983 - $27,640
354 Added 5.53%
6,753 $427,000
Q2 2020

Jul 31, 2020
BUY
$72.34 - $84.0 $56,352 - $65,436
779 Added 13.86%
6,399 $492,000
Q1 2020

Apr 24, 2020
BUY
$62.63 - $80.22 $89,811 - $115,035
1,434 Added 34.26%
5,620 $421,000
Q4 2019

Feb 07, 2020
SELL
$61.62 - $67.78 $7,640 - $8,404
-124 Reduced 2.88%
4,186 $272,000
Q3 2019

Nov 06, 2019
BUY
$62.51 - $69.0 $9,376 - $10,350
150 Added 3.61%
4,310 $274,000
Q2 2019

Aug 06, 2019
SELL
$61.87 - $69.38 $24,500 - $27,474
-396 Reduced 8.69%
4,160 $281,000
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $50,524 - $56,600
808 Added 21.56%
4,556 $296,000
Q4 2018

Feb 08, 2019
SELL
$60.54 - $79.0 $37,595 - $49,059
-621 Reduced 14.21%
3,748 $234,000
Q3 2018

Nov 06, 2018
SELL
$71.28 - $78.92 $54,315 - $60,137
-762 Reduced 14.85%
4,369 $337,000
Q2 2018

Aug 08, 2018
SELL
$64.88 - $75.68 $47,492 - $55,397
-732 Reduced 12.49%
5,131 $364,000
Q1 2018

May 09, 2018
SELL
$72.84 - $88.8 $534,864 - $652,058
-7,343 Reduced 55.6%
5,863 $442,000
Q4 2017

Feb 13, 2018
BUY
$71.15 - $83.52 $524,162 - $615,291
7,367 Added 126.17%
13,206 $946,000
Q3 2017

Oct 31, 2017
SELL
$72.11 - $85.47 $91,147 - $108,034
-1,264 Reduced 17.8%
5,839 $473,000
Q2 2017

Aug 07, 2017
BUY
N/A
7,103
7,103 $502,000

Others Institutions Holding GILD

# of Institutions
1,893
Shares Held
1.02B
Call Options Held
12M
Put Options Held
9.04M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email